New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin
COMPASS Pathways’ (CMPS) patent for crystalline psilocybin is being challenged by the non-profit Freedom to Operate. After conducting advanced analysis, the organization is confident that the formulation isn’t novel and has been known for decades.
